Cytocast Secures 1.65M Euros in Second Investment Round to Accelerate Innovation and Growth

🎉 Exciting Announcement from Cytocast! 🎉  

🌟 We are thrilled to announce the successful completion of our second investment round, where we secured a total funding of 1.65 million Euros from industry-leading venture capital firms. We extend a warm welcome to Bonitás, KDT Holding, Fastventures, Futurmed, and ZoirosVentures, who share our vision of advancing the healthcare industry through data-driven medical technology. Join us in celebrating this significant achievement and stay tuned for more updates on shaping the future of drug discovery, personalized treatments, and patient care. 🤝💊   

Stay tuned for exciting developments! 💡